Evidence map›Paper›PMID 35187406›Full record

ArticleHemaSphere2022

Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis.

Nora Liebers, Stefan O Schönland, Claudius Speer, Dominic Edelmann, Paul Schnitzler, Hans-Georg Kräusslich, Carsten Mueller-Tidow, Ute Hegenbart, Sascha Dietrich

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nora LiebersDepartment of Medicine V, Heidelberg University Hospital, Germany.
Stefan O SchönlandDepartment of Medicine V, Heidelberg University Hospital, Germany.
Claudius SpeerDepartment of Nephrology, Heidelberg University Hospital, Germany.
Dominic EdelmannGerman Cancer Research Center, Division of Biostatistics, Heidelberg, Germany.
Paul SchnitzlerDepartment of Infectious Diseases, Virology, Heidelberg University Hospital, Germany.
Hans-Georg KräusslichDepartment of Infectious Diseases, Virology, Heidelberg University Hospital, Germany.
Carsten Mueller-TidowDepartment of Medicine V, Heidelberg University Hospital, Germany.
Ute HegenbartDepartment of Medicine V, Heidelberg University Hospital, Germany.
Sascha DietrichDepartment of Medicine V, Heidelberg University Hospital, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35187406
PMCPMC8849404

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.